| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2021―Mar―11 |
COVID-19 infection causes a reduction in neutrophil counts in patients taking clozapine |
Siobhan Gee, David Taylor |
| 2 |
[GO] |
2021―Mar―05 |
Elevated clozapine levels and toxic effects after SARS-CoV-2 vaccination |
Deborah Thompson, Clay M. Delorme, Randall F. White, William G. Honer |
| 3 |
[GO] |
2020―Jun―26 |
Clozapine and COVID-19 |
Gary Remington, Valerie Powell |
| 4 |
[GO] |
2020―Jun―26 |
Adapting to the impact of COVID-19 on mental health: an international perspective |
Rejish K. Thomas, Raheem Suleman, Marnie Mackay, Lovneet Hayer, Mohit Singh, Christoph U. Correll, Serdar Dursun |
| 5 |
[GO] |
2020―Jun―26 |
Clozapine and COVID-19: The authors respond |
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich |
| 6 |
[GO] |
2020―Apr―28 |
Consensus statement on the use of clozapine during the COVID-19 pandemic |
Dan Siskind, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich |
|
